Extracorporeal Membrane Oxygenation Characteristics and Outcomes in Children and Adolescents With COVID-19 or Multisystem Inflammatory Syndrome Admitted to U.S. ICUs.

ABSTRACT:

Objectives

Extracorporeal membrane oxygenation (ECMO) has been used successfully to support adults with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related cardiac or respiratory failure refractory to conventional therapies. Comprehensive reports of children and adolescents with SARS-CoV-2-related ECMO support for conditions, including multisystem inflammatory syndrome in children (MIS-C) and acute COVID-19, are needed.

Design

Case series of patients from the Overcoming COVID-19 public health surveillance registry.

Setting

Sixty-three hospitals in 32 U.S. states reporting to the registry between March 15, 2020, and December 31, 2021.

Patients

Patients less than 21 years admitted to the ICU meeting Centers for Disease Control criteria for MIS-C

SUBMITTER: Bembea MM 

PROVIDER: S-EPMC10153593 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature